Sammy Saab, MD, MPH, on Before Initiating DAAs, Screen for Hep B

 

Sammy Saab, MD, MPH, from the Ronald Reagan UCLA Medical Center explains the potentially deadly consequences of hepatitis B reactivation in patients being treated for hepatitis C, and why screening for hepatitis B before starting direct-acting antiviral therapy is crucial.

Sammy Saab, MD, MPH, AGAF, FAASLD, FACG, is a board-certified hepatologist at the Ronald Reagan UCLA Medical Center in Los Angeles, California. He is on the editorial board of more than a dozen journals and has been named one of the "Best Doctors in America."

Check out our Hepatitis C Microsite!

Submit Feedback

Name